CD34 and acute myeloid leukemia: To determine whether HOXBLINC is aberrantly expressed along with the HOXB genes in AML, we performed RT-qPCR on bone marrow mononuclear cells (BMMNCs) from a cohort of AML patients (NPM1c+, n = 25; and NPM1-wt, n = 40; see patient information in Supplementary Table 1) as compared to both BMMNCs (n = 16) and CD34+ cells (n = 11) from healthy individuals.